Industries We Serve with Our Market Access, Quality Compliance & Regulatory Affairs Consulting Services

Cisema provides trusted regulatory affairs consulting services to help companies succeed across the Asia Pacific region. With deep expertise in China and the Hong Kong SAR, and expanding support across Southeast Asia and Taiwan, we work with clients in diverse regulatory environments. Backed by decades of experience in regulatory affairs consulting, our team of regulatory experts delivers comprehensive regulatory services, providing end-to-end support for compliance and approvals. We have a proven track record of achieving successful regulatory outcomes for medical devices, IVDs, pharmaceuticals, cosmetics, health products, consumer goods, and industrial products. Our expert guidance ensures smooth market entry, regulatory compliance, and long-term success in one of the world’s most dynamic regions.

Two men in business suits sitting at a table engaged in a meeting with a third person.
Regulatory submissions

Industries We Serve

We support companies in over 16 regulated industries, with a focus on streamlining compliance and approvals for our clients. We help them meet the evolving regulatory landscape and compliance requirements, accelerate approvals, and maintain product quality throughout the lifecycle. For each industry, we develop a tailored regulatory strategy and identify the optimal regulatory pathway to ensure efficient progression through approval stages and reduce risks.

Medical Devices

We assist manufacturers with product registration, clinical trials, post-market surveillance, quality control, and the implementation of quality management systems. As well as inspection and sourcing services, in China, Hong Kong and Taiwan and across Southeast Asia.

In Vitro Diagnostics (IVDs)

Our team helps IVD companies navigate rigorous clinical validation, registration, and post-market requirements, ensuring compliance with the latest regulatory and clinical guidelines. We also deliver quality control, inspection, and sourcing services across China, Hong Kong, Taiwan and Southeast Asia.

Pharmaceuticals

From early development through to commercialization, we support drug manufacturers throughout the entire drug development process, providing strategic guidance, submission support, and GMP alignment for success across Asia Pacific.Our team has extensive expertise in the preparation and submission of drug applications, including ANDAs and NDAs, ensuring regulatory compliance and smooth interactions with agencies.

Biotech

We provide regulatory guidance for biotech innovators across Asia Pacific, supporting clinical trial design, biosafety clearance, import licensing, and alignment with regulators' expectations.

Cosmetics & Ingredients

We support cosmetic and ingredient manufacturers throughout the full product lifecycle in China and Taiwan from pre-registration or notification to post-market. We are your “Responsible Person” and ensure quality compliance with Chinese and Taiwanese regulations, assisting in preparation for NMPA and TFDA audits as required.

Health Foods & Supplements

We handle regulatory strategies, raw material approvals, testing, and registrations for dietary supplements and health foods. Our team ensures quality compliance and smooth market entry.

Veterinary Drugs & Pet Food

We support MARA interactions, registration, licensing, and testing for pet foods and veterinary medicinal products entering the Chinese market.

Industrial Goods & Consumer Products

We help you get your products on the market faster, from electronics and toys to machinery, telecom, and automotive parts. Our team manages CCC, HAF 604, CML, CEL, RoHS, NAL, SRRC, and more. From testing and documentation to renewals and authority approvals, we streamline every step to ensure full compliance with China’s regulations.

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Why Work with Cisema

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
April 18, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

How Cisema Supported Inox Torres Group, S.L. in Successfully Renewing its China Manufacture License (SELO) for Level A2 Pressure Vessels

The China Manufacture License (CML), also known as the SELO license, is a mandatory requirement for manufacturers of pressure equipment intended for the Chinese market. Inox Torres Group, S.L.’s manufacturing site produces high-pressure vessels falling under the Level A2 scope. This license ensures compliance with China’s stringent quality and safety regulations for special equipment.

The Challenge: Managing SELO Complexity for High-Risk Equipment

Renewing a SELO license for Level A2 pressure vessels required careful coordination across regulatory, technical, and cultural dimensions.

  • Navigating Regulatory Complexity
    Navigating the complex and evolving SELO regulatory framework, particularly for high-risk products under Level A2, required meticulous planning and real-time compliance updates.
  • Ensuring Audit Readiness
    Inox Torres Group, S.L. needed to ensure all documentation and procedures were fully up to date and to select an appropriate demo product that met inspection requirements.
  • Managing Inspector Expectations
    Success depended on understanding the unspoken cultural and procedural expectations of SELO inspectors, including hosting and on-site hospitality.

Our Solution: Full-Spectrum SELO Audit Support

Recognizing the high stakes of SELO license renewal, Inox Torres Group, S.L. engaged Cisema for comprehensive regulatory and strategic support.

  • Reviewed the Quality Management System
    Cisema led the review and upgrade of the customer’s quality management system in line with the latest Chinese requirements, including a comprehensive gap analysis and revision of key documentation.
  • Audit Simulation & Preparation
    A preparatory remote audit simulation was conducted, walking through every step of the audit to ensure full readiness ahead of the on-site inspection.
  • Delivered On-Site Bilingual & Regulatory Support
    During the on-site audit, Cisema provided continuous bilingual support, interpreting inspector questions in real time and translating regulatory nuances for the customer.
  • Provided Culturally Appropriate Inspector Hosting
    Cisema arranged culturally appropriate corporate hospitality, helping establish a respectful and positive tone for the inspection. The team remained onsite throughout all audit days, including the weekend, to ensure no detail was overlooked.

The Outcome: Successful Renewal Without Disruption

Through hands-on execution and close coordination, the SELO renewal process was completed smoothly and efficiently.

  • Secured CML Renewal with Full A2 Status
    Inox Torres Group, S.L. successfully renewed its China Manufacture License for pressure vessels, maintaining its Level A2 classification.
  • Executed the Project Efficiently
    Full regulatory preparation and audit execution were completed within six months.
  • Achieved Seamless Inspector Coordination
    SELO inspectors were hosted and coordinated smoothly, with culturally aligned engagement throughout the audit.
  • Secured Regulatory Continuity  
    The renewal avoided operational disruptions and ensured compliance with updated SELO requirements.

Expertise and Efficiency: Acting as an Extension of the Client Team

Cisema’s experienced consultants acted as an extension of Inox Torres Group, S.L.’s regulatory and quality teams, providing both regulatory expertise and strategic foresight. Inspector concerns were anticipated and addressed proactively, transforming a potentially stressful process into a streamlined, well-orchestrated engagement with Chinese authorities.

Hands-on mentoring throughout the project helped the customer gain confidence and clarity in managing future SELO audits.

Why Choose Cisema

  • Strategic Regulatory Expertise: Deep understanding of Chinese bureaucracy, evolving SELO requirements, and inspector expectations.
  • Mentorship & Training: Step-by-step guidance that supported the customer’s quality team throughout the process.
  • Corporate Hospitality Excellence: Culturally aligned hosting that supports successful audit outcomes in China.
  • Audit Readiness & Precision: Gap analysis, audit simulation, and documentation refinement to pass SELO reviews efficiently.
  • End-To-End Support: Full management of the audit process, from document revision to on-site interpretation.

Further Information

Explore Cisema’s China Special Equipment (SELO) Certification services.

Learn More
China Manufacture License Renewal for Level A2 Pressure Vessels
Previous
Previous

Latest Insights

View More

Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices

Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements

April 17, 2026
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Two professionals in an office review documentation for a HealthScreen glucose monitor while examining a computer display showing a product label with model number, barcode, and QR code. One person points to the code on the screen as the other reads.

Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens

Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.

April 17, 2026
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Two office professionals sit at a desk in an office reviewing cosmetic and skincare product packaging alongside printed documents and binders. One person examines a product bottle while the other works on a laptop, suggesting regulatory compliance review.

BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation

BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.

April 17, 2026
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
Laboratory scientist wearing a lab coat, protective goggles, gloves, and a blue hair cover carefully examining a small vial of liquid in a modern laboratory. A tray of sample vials sits on the bench in front.

Vietnam Draft Cosmetic Decree Signals Tougher Compliance Environment

Vietnam’s draft cosmetic management decree would replace existing rules and strengthen post-market controls for cosmetic companies.

April 17, 2026
Vietnam Draft Cosmetic Decree Signals Tougher Compliance Environment

Vietnam Cuts Advertising Red Tape for Healthcare Products

Vietnam’s MoH recently published Circular drops several healthcare advertising regulations and streamlines requirements for many categories.

April 17, 2026
Vietnam Cuts Advertising Red Tape for Healthcare Products

Malaysia Introduces Reliance and Priority Review Mechanisms for Additional Drug Indication Applications

Malaysia’s NPRA introduces reliance and priority review pathways for additional indications of registered innovator drugs.

April 17, 2026
Malaysia Introduces Reliance and Priority Review Mechanisms for Additional Drug Indication Applications
Previous
Previous

Get in Touch with Our Regulatory Affairs Experts

And discover how we can support you across your various projects in Asia Pacific.

Request Proposal